Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Ciprofloxacin for UTI Reduction After Botox for Overactive Bladder
NCT04444440Phase 4Recruiting
- Sponsor
- University of Alberta
- Start
- Jun 2021
- Primary completion
- Jun 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ciprofloxacin in urinary tract infection (UTI), sponsored by University of Alberta. Started Jun 2021; status: recruiting.
02
Drugs
ciprofloxacin
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT04444440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04444440.